PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of hccpBioMed CentralBiomed Central Web Sitesearchsubmit a manuscriptregisterthis articleHereditary Cancer in Clinical PracticeJournal Front Page
 
Hered Cancer Clin Pract. 2010; 8(Suppl 1): P7.
Published online 2010 May 25. doi:  10.1186/1897-4287-8-S1-P7
PMCID: PMC2876302

Large serrated polyps: molecular and familial links to a serrated neoplasia predisposition

Abstract

Background

The serrated pathway to colorectal cancer is associated with a CpG-island methylator-phenotype (CIMP) and is distinct of the classical adenoma-to-carcinoma sequence. There is increasing evidence that a subset of hyperplastic polyps (HPs) serves as intermediates in an oncogenic sequence resulting in a CIMP colorectal cancer. This study analyzes molecular changes in large HPs to define their potential relationship to the serrated polyp pathway and links them to a predisposition to colorectal cancer.

Methods

Large serrated polyps (>20 mm) were identified by review of a colorectal polyp database and corresponding paraffin-embedded pathology specimens were retrieved. DNA was isolated from tissue blocks and methylation-specific quantitative real-time PCR analysis (MethyLight) was used to determine CIMP status (5 marker panel), methylation of mutated in colon cancer (MCC) gene, and the MLH1 gene. Polyp DNA was screened for mutations in the oncogenes KRAS and BRAF. Patient personal and family history of colorectal cancer was reviewed.

Results

Thirty-four large serrated polyps were studied. 28 were analyzed for BRAF of which 26 (93%) were mutant at V600E. 30 polyps were analyzed for CIMP, of which 18 (60%) were CIMP+. Of the 28 BRAF mutants, 20 had CIMP analysis done as well: 12/20 (60%) were CIMP+ and 8/20 (40%) were CIMP-. Of the 12 CIMP+, BRAF mutant polyps, 3 of 4 had methylated MCC but none of 4 had methylated MLH1. All polyps were KRAS wild type. 22 patients with large serrated polyps had an available personal and family history. Eight of 22 (36%) had a personal and 6 of 22 (27%) had a family history of colorectal cancer. Six of the eight (75%) with a personal history and 3 of the 6 (50%) with family history of colorectal cancer were CIMP+.

Conclusions

Large serrated polyps represent a subset of serrated lesions that appear to be initiated by BRAF mutations and progress toward cancer through subsequent methylation events. These polyps are associated with significant personal and familial history of colorectal neoplasia and likely represent part of a serrated neoplasia disposition.


Articles from Hereditary Cancer in Clinical Practice are provided here courtesy of BioMed Central